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Anti-inflammatory, anti-bacterial and anti-acetylcholinesterase activities of
two isoquinoline alkaloids-scoulerine and cheilanthifoline
Abstract

Corydalis plants containing isoquinoline alkaloids are reported to possess promising pharmacological
properties for the treatment of important diseases including cancer, inflammation, Alzheimer's disease and
microbial infections. As part of a wider program investigating Bhutanese medicinal plants, we have previously
identified eight isoquinoline alkaloids from C. dubia. Out of these, we report here on two of the major
alkaloids, scoulerine (1) and cheilanthifoline (2) and their inhibitory activities against acetylcholinesterase
(anti-AChE), tumor necrosis factor alpha (anti TNF-α) and a bacterial strain, Helicobacter pylori. Both
alkaloids showed weak anti TNF-α and antibacterial activities. However, the anti-AChE activity of scoulerine
(1) was promising as it significantly inhibited AChE with a minimum inhibitory requirement (MIR) value of
0.0015 nmol, which was two-fold better than the reference drug, galanthamine (MIR value of 0.003 nmol). As
there are limited anti-Alzheimer's chemotherapeutics, scoulerine (1) is worthy of further exploration,
including lead optimization, structure-activity-relationship studies, analog development, pharmacodynamics
and in vivo animal studies.
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Corydalis plants containing isoquinoline alkaloids are reported to possess promising pharmacological properties for the treatment of important diseases
including cancer, inflammation, Alzheimer’s disease and microbial infections. As part of a wider program investigating Bhutanese medicinal plants, we have
previously identified eight isoquinoline alkaloids from C. dubia. Out of these, we report here on two of the major alkaloids, scoulerine (1) and cheilanthifoline
(2) and their inhibitory activities against acetylcholinesterase (anti-AChE), tumor necrosis factor alpha (anti TNF-α) and a bacterial strain, Helicobacter pylori.
Both alkaloids showed weak anti TNF-α and antibacterial activities. However, the anti-AChE activity of scoulerine (1) was promising as it significantly
inhibited AChE with a minimum inhibitory requirement (MIR) value of 0.0015 nmol, which was two-fold better than the reference drug, galanthamine (MIR
value of 0.003 nmol). As there are limited anti-Alzheimer’s chemotherapeutics, scoulerine (1) is worthy of further exploration, including lead optimization,
structure-activity-relationship studies, analog development, pharmacodynamics and in vivo animal studies.
Keywords: Acetylcholinesterase inhibitor, Isoquinoline alkaloid, Anti-inflammatory, Antimicrobial, Medicinal plant, Corydalis dubia.

Historically, natural products have played an important role in
traditional medicines and drug discoveries. Drugs discovered from
natural sources, especially medicinal plants, continue to provide
new drug lead compounds and also enter clinical trials, particularly
as antimalarial, anticancer and antimicrobial agents. A detailed
analysis of new medicines approved by the US Food and Drug
Administration (FDA) between 1981 and 2010 revealed that 34% of
those medicines that were based on small molecules were natural
products or direct derivatives of natural products [1-2]. Medicinal
plants belonging to the genus Corydalis (Family Papaveraceae) are
known to contain drug-like bioactive isoquinoline alkaloids with
promise for treating inflammation, microbial infections, cancers,
and Alzheimer’s disease (AD) [3].
As part of a wider program investigating Bhutanese medicinal
plants, we have previously carried out phytochemical and biological
activity studies of the three Bhutanese Corydalis species (C.
calliantha, C. crispa and C. dubia), which resulted in the
identification of number of isoquinoline alkaloids with potent
antimalarial activity against the multidrug resistant Plasmodium
falciparum strain [4-7]. The crude MeOH and CHCl3 extracts of C.
dubia showed anti-inflammatory activity with 58% and 62%
inhibition of TNF-α production, respectively, in LPS activated
THP-1 cells [8]. Traditionally, this medicinal plant is indicated for
treating impure blood (detox), fever arising from infections of the
liver, heart, lung, pancreas and kidney, and in alleviating neuralgia
and complicated disorders (combination of defective air, bile and
phlegm) that bore relevance to the symptoms of inflammation,
microbial infections and AD [4]. Considering these, we have further
investigated two major isoquinoline alkaloids - scoulerine (1) and
cheilanthifoline (2) (Figure 1) for their anti-inflammatory, antibacterial and the anti-acetylcholinesterase (anti-AChE) activities.
These two alkaloids are related since they are both biosynthesized
in plants from tyrosine [9]. Protopine, one of the major alkaloids of
this plant, is biosynthetically related to these two alkaloids and has
shown broad-spectrum bioactivities, especially anti-inflammatory

and AChE inhibitory activities [6,10-11].

Scoulerine (1)

Cheilanthifoline (2)

Figure 1: Structure of the two major isoquinoline alkaloids (isolated from C. dubia),
which were tested for their anti-inflammatory, anti-bacterial and antiacetylcholinesterase activities.

Our studies revealed that scoulerine (1) and cheilanthifoline (2) also
possess broad-spectrum biological activities. Both these alkaloids
exhibited weak antibacterial and anti-inflammatory properties, but
showed strong –moderate anti-acetylcholinesterase activity (Table
1). Plant derivatives are clinically known for their antiinflammatory properties [12]. Out of 171 alkaloids isolated between
1907 and 2000, 137 were reported to have anti-inflammatory
properties [13].
Table 1: Anti-AChE, anti-TNF-α and antibacterial activities of compounds 1 and 2
from C. dubia.
Compds/positive
controls
MeOH extract
1
2
Galanthamine a
Dexamethasoneb

Anti-AChE*
MIR (nmol)
0.0015
0.31
0.003

Anti-TNF-α**
TNF-α
(pg/mL) % inhibition
566 ± 17 − (9)
541 ± 33

− (13)

258 ± 65

− (58)

Antimicrobial***
H. pylori
MIZ (mm) MIC (µ g/mL)
6
2000
5

250
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1% DMSO/RPMIc
Amoxicillind

620 ± 54

Vehicle
7

16

−: inhibited; *Acetylcholinesterase inhibitory activity. **Anti-inflammatory activity
with measurement of TNF-α (in pg/mL) when co-cultured with the test compounds and
their % inhibition. ***Antimicrobial activity against H. pylori showing both minimum
inhibition zone (MIZ) and minimum inhibitory concentrations (MIC). Compounds were
tested against seven bacterial and one fungal strain and the result shows only the
compound-susceptible strain. aReference drug for acetylcholinesterase activity.
b
Reference drug for anti-inflammatory activity. c Vehicle control for anti-inflammatory
assay. dReference drug for antimicrobial activity

Corydalis species have been widely studied for their antiinflammatory isoquinoline alkaloids and many of them, especially
tetrahydropalmatine (isolated from C. yanhusuo), pseudocoptisine
(isolated from C. turtschaninovii) and ochotensimine (isolated from
C. impatiens), significantly inhibited the production of IL-6, IL-8,
TNF-α and also other mediators that are involved in the
inflammation process [3]. In inflammatory diseases, the proinflammatory cytokine, TNF-α, plays a central role in inflammation
and autoimmune diseases. Thus, the pro-inflammatory cytokine
(TNF-α) in bacterial lipopolysaccharide (LPS) activated THP-1
cells are commonly used for evaluating the anti-inflammatory
effects of various plant materials [6,14]. Using this model, we have
earlier investigated the anti-inflammatory activity of the crude
methanol extract of C. dubia and showed that it significantly
inhibited the production of pro-inflammatory cytokine –TNF-α with
62% inhibition, which appeared better than the positive control
(dexamethasone) with 58% inhibition [8]. Encouraged by this, we
have further investigated the anti-inflammatory activity of the two
major compounds – scoulerine (1) and cheilanthifoline (2) –
isolated from C. dubia. Both compounds exhibited only weak antiinflammatory activity (Table 1). Of the two compounds tested,
cheilanthifoline (2) inhibited TNF-α cytokine production in LPS
activated THP-1 cells by 13% in comparison with the solvent
control (1% DMSO/RPMI). Since compounds 1 and 2 did not show
significant anti-TNF-α activities, we believe that there may be some
minor chemical components in the crude extract, which were lost
during our isolation process.
Corydalis species and their isoquinoline alkaloids have also
demonstrated antimicrobial properties including antiviral, antifungal
and antibacterial [3,15]. Li and co-workers studied in vitro antiHelicobacter pylori activity of 30 Chinese herbal medicines used
for treating gastric ulcers in traditional medicine of China and
discovered that the ethanolic extract of C. yanhusuo showed
moderate antibacterial activity with a MIC value of 60 mg/mL [3].
Antimicrobial activity is assessed by both agar well diffusion (based
on the zone of inhibition) and broth dilution (minimum inhibition
concentration) methods. According to the broth dilution screening
method for antimicrobial activity of higher plants, a prominent
antibacterial effect worthy of further investigation is said to be as
low as 1/32 dilutions-based inhibitory activities [16-17]. Rojas et al.
[18] considered plant extracts and derivatives as bioactive
antimicrobials if the MIZ is ≥3 mm well diameter. Svetaz et al.
[19], Mohamad et al. [20] and Geyid et al. [21] reported plant
extracts and their constituents as antimicrobial agents if their
minimum inhibition concentrations (MIC) were in the range of
1000 - 4000 µg/mL. This suggests that a researcher can set the
criteria of antimicrobial activity depending upon their interest of
microbial strains under investigation. In this study, we have
interpreted the results of test compounds as inhibitory only if the
MIZ was ≥5 mm well diameter or if their MIC was ≤300 µg/mL.
Values below 5 mm well diameter or above 300 µg/mL were
considered either as inactive or not showing inhibition. We first
assessed the inhibition zones of scoulerine (1) and cheilanthifoline
(2) against seven bacterial strains (Escherichia coli, Bacillus
subtilis, Staphylococcus aureus, methicillin resistant S. aureus

(MRSA), S. epidermidis, Vibrio cholerae, and Helicobacter pylori)
and one yeast strain (Candida albicans), and then finally
determined the MIC of the compounds that showed MIZs of ≥5 mm
well diameter. While cheilanthifoline (2) showed the higher MIZ of
6 mm against only B. subtilis and H. pylori, this activity did not
translate proportionately when its MIC was determined (MIC =
2000 µg/mL, not active). On the other hand, scoulerine (1) showed
a MIZ of 5 mm against the H. pylori strain (Table 1) and
demonstrated a better MIC value (250 µg/mL) in comparison with
cheilanthifoline (2). The crude extracts of C. dubia, from which
compounds 1 and 2 were isolated, exhibited weak antibacterial
activity against S. aureus, MRSA, B. subtilis and S. epidermidis
with MIZs of 5–6 mm [4]. Both alkaloids were inactive against the
bacterial and yeast strains tested here.
Corydalis species are known AChEIs [3,22]. Acetylcholinesterase
(AChE) is responsible for the termination of nerve impulse
transmission at the cholinergic synapses by rapid hydrolysis of
acetylcholine (ACh), which is a neurotransmitter linked to
Alzheimer's disease (AD). AD affects more than 20 million people
every year and is increasing [23]. Drug discovery within the AD
field has for the last 20 years been rather amyloidcentric and only
recently have other mechanisms and targets for screening been
considered, including ones connected to inflammation, oxidative
stress and the mechanistic intervention approach by targeting
neurotransmitter dysfunction. Inhibitors of AChE currently form the
basis of drugs for the management of AD, including the alkaloid –
galanthamine, which was isolated from Galanthus woronowii [24].
AChE inhibitors (AChEI) increase the availability of acetylcholine
in central cholinergic synapses and improve memory and cognitive
deficits of the patients by diminishing the breakdown of
acetylcholine at the synaptic site in the brain [3, 22-23]. Various
assay protocols to screen for AChEI exist [23,25] and the choice of
an appropriate screening assay is crucial. Di Giovanni et al. [26]
have compared two colorimetric screening assays frequently used to
detect acetylcholinesterase inhibitory activity (Marston et al. [27]
and Ellman et al. [28]) involving a test set of 138 compounds. They
obtained similar results and concluded that both AChE inhibitory
screening assays are suitable for the generation of new hits. In this
study, we used the method described by Marston et al. [27] and
interpreted the result as described in Sastruruji et al. [29]. The TLC
plate loaded with varying concentrations of the test compounds was
sprayed with AChE enzyme stock solution, which was prepared
from acetylcholinesterase of electric eels (EC 3.1.1.7, 906 U/mg).
Structures of the human recombinant and eel enzymes are very
similar [23], but they cannot be considered as identical, nor will
inhibitors as a rule give identical results. Of the two alkaloids
tested, scoulerine (1) exhibited a highly significant AChE inhibitory
activity at a 1 ng concentration with a minimum inhibitory
requirement (MIR) value of 0.0015 nmol, which was two-fold
better than the reference drug, galanthamine (1 ng) with a MIR
value of 0.003 nmol (Table 1). Cahlikova et al. [30] earlier reported
that this same compound exhibited anti-AChE activity with an IC50
value of 245 µM against human AChE using the method described
by Ellman et al. [28]. Obviously, the results of these two studies
(ours versus Cahlikova et al. [30]) cannot be compared since
different materials and methods were used, including target
enzymes, colorimetric methods and the plant species. However,
both these studies validated that scoulerine (1), though obtained
from two different plant species (Eschscholzia californica and C.
dubia), is a good AChEI. Cheilanthifoline (2) exhibited moderate
AChE inhibitory activity with a MIR value of 0.31 nmol.
In conclusion, our study showed that scoulerine (1) and
cheilanthifoline (2) have broad-spectrum biological activities, such
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as anti-inflammatory, antibacterial and anti-AChE. These findings
validated the traditional uses of C. dubia in Bhutanese medicine.
We also confirmed that scoulerine (1) is a good AChEI. This
alkaloid is a simple, non-toxic, small molecule [7] and has the
physio-chemical properties of drug-like compounds that meet the
criteria of the Lipinski rule of 5 [31]. Considering this, scoulerine
(1) is worthy of further exploration including lead optimization,
structure-activity-relationship studies, analogue development,
pharmacodynamics and in vivo animal studies.
Experimental
Plant materials and preparation of compounds for biological
testing: Corydalia dubia Prain was collected, processed and
chemically assessed, as previously described by us [7]. Briefly,
alkaloids 1 and 2 (along with 6 other alkaloids, as described in
Wangchuk et al. [7]) were obtained through acid-base fractionation
of extracts focusing on the alkaloids and then repeatedly purified by
column and preparative thin layer chromatography (PTLC). Final
separation of the basic fraction using PTLC plates with a mobile
phase - CHCl3/ethyl acetate (55:45 v/v) yielded scoulerine (1) and
the other fraction furnished cheilanthifoline (2) (PTLC plate in a
mobile phase of CHCl3/ethyl acetate/NH4OH) (55:45:4 drops).
Stock solutions of these compounds were prepared in accordance to
the requirements of different assay protocols.
Anti-AChE activity assay: The AChE inhibitory activity of
scoulerine (1) and cheilanthifoline (2) were determined using the
rapid TLC bioautographic method described by Marston et al. [27]
and Sastraruji et al. [29]. The TLC plates were washed with
acetone, dried, and the test compounds applied to the plates in
varying quantities. The plate was sprayed with AChE enzyme stock
solution, which was prepared from acetylcholinesterase of electric
eels (EC 3.1.1.7, 906 U/mg). The plates were incubated at 37°C for
20 min and then sprayed with freshly prepared indicator solution
(made from 1-naphthyl acetate and Fast Blue B salt to give the plate
a purple coloration after 1-2 min); the compounds that inhibited
AChE exhibited white spot on the plates. Galanthamine was used as
a reference compound. The tests were performed in triplicate.
Anti-inflammatory assay: This assay was performed as previously
described [6,8,14]. Briefly, THP-1 human monocytic cell lines
(ATCC, TIB 202) were maintained in RPMI 1640 (GibcoInvitrogen, USA) supplemented with 10% fetal bovine serum
(Gibco-Invitrogen, USA) in tissue culture flasks (Corning, USA)
and were incubated (37°C in humidified 5% CO2 incubator). For
bioassays, cells were counted with a hemocytometer under an
inverted microscope (Nikon TMS No. 300679: Nikon, Japan) and
diluted to desired cell densities. THP-1 cells (200 µL) were seeded
in 96-well tissue culture plates (Corning, USA) at a final density of
2.5 x105 cells/mL. Cells were incubated with the compounds alone
or in combination with purified LPS (100 ng/mL) from Escherichia
coli serotype O127 : B8 (Sigma, USA) for 3.5 h. Supernatants were
collected from individual wells by centrifugation and assayed for
TNF-α. The cell viability of compounds in THP-1 cells was
determined by the Trypan-blue (Gibco-Invitrogen, USA) stain
exclusion assay. Cells were incubated with varying concentration of
compounds (0, 1.95, 3.9, 7.8, 15.6 and 31.25 µg/mL). The cell

suspension was mixed with Trypan Blue, which stained dead cells.
The percentage of cell viability was calculated by the formula: %
Cell viability = 100 × (1−(dead cells/total cells)). TNF-α production
in THP-1 cell culture supernatants was measured using cytokinespecific sandwich quantitative enzyme-linked immunosorbent
assays (ELISAs) according to the manufacturer’s instructions (R &
D Systems, USA). Recombinant human TNF-α was used as
standard at concentrations of 15.6, 31.5, 62.5, 125, 250, 500, and
1000 pg/mL. Absorbance was measured at 450 nm using a BioTek®
Synergy™ HT (Multi-Detection Microplate Reader, USA).
Cytokine concentration in each well was quantified from a standard
curve and expressed as pg/mL of culture medium. A commercial
anti-inflammatory drug, dexamethasone (10 µg/mL), (Atlantic
LabsComp. Ltd., Thailand) was used as a positive control. The
experiments were performed 3 times in triplicate. The percentage of
TNF-α inhibition was calculated by the formula: % TNF-α
inhibition = 100 × ((observed/baseline) − 1). Where observed =
secreted TNF-α of experiment (pg/mL) and baseline = secreted
TNF-α of DMSO (pg/mL).
Antimicrobial test methods: The antimicrobial assay was
performed as previously described [4,6,32]. Briefly, 7 bacterial
strains (Escherichia coli (ATCC 25922), Bacillus subtilis (ATCC
6633), Staphylococcus aureus (ATCC 6538), methicillin resistant S.
aureus (MRSA), (DMST 20651), S. epidermidis (ATCC 12228),
Vibrio cholerae (DMST 2873), and Helicobacter pylori (H40)) and
on YEAST strain {Candida albicans (ATCC 10231)} were used for
the study. C. albicans was grown on Sabouraud Dextrose Agar
(SDA) (Becton Dickinson, USA) and incubated (25 °C, 24-48 h). H.
pylori was grown on Brain Heart Infusion (BHI) agar (Becton
Dickinson, USA) supplemented with horse serum (10%) (GIBCO
Invitrogen, England) and incubated (at 37°C for 3 days) under
micro-aerobic conditions (5% O2, 10% CO2, 85% N2) generated by
using a micro-aerobic GasPak (Mitsubishi, Japan) in an anaerobic
jar (Mitsubishi, Japan). Other bacterial strains were grown on
Mueller Hinton Agar (MHA) (Becton Dickinson, USA) under
aerobic conditions (37°C, 24 h). The inocula of test organisms were
prepared in appropriate broth by adjusting to the McFarland
standard. A modified agar well diffusion method (AWD) [33-34]
was used for determining the minimum inhibition zones (MIZ in
mm diameters) for each compound. The MIC was examined by the
broth microdilution method, as described by Wayne [35]. A serial
two-fold dilution of each compound prepared in 96-well microtiter
plates (Corning, USA) (stock concentration of 3 mg/mL) was used
for measuring the minimum inhibitory concentration (MIC).
Amphotericin B (Sigma-Aldrich,USA), vancomycin (Edicin,
Slovenia)
and
amoxicillin
(Government
Pharmaceutical
Organization, Thailand) were used as reference drugs against the
yeast, MRSA and other bacterial strains, respectively. DMSO and
distilled water were used as controls. The experiments were
performed 3 times in duplicate.
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